The company's fundamentals are relatively very healthy. Its valuation is considered fairly valued,and institutional recognition is very high. Over the past 30 days, multiple analysts have rated the company as a Buy. Despite a weak stock market performance, the company shows strong fundamentals and technicals. The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.
Score
Industry at a Glance
Industry Ranking
5 / 208
Overall Ranking
69 / 4730
Industry
Healthcare Equipment & Supplies
Support & Resistance
No Data
Score Analysis
Current score
Previous score
Analyst Rating
Based on
11
analysts
Buy
Current Rating
104.400
Target Price
+17.58%
Upside Space
Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.
Company Highlights
StrengthsRisks
Merit Medical Systems, Inc. is engaged in the development, manufacture, and distribution of proprietary medical devices used in interventional, diagnostic, and therapeutic procedures, particularly in cardiology, radiology, oncology, critical care, and endoscopy. Its segments include cardiovascular and endoscopy. Its cardiovascular segment consists of four product categories: peripheral intervention, cardiac intervention, custom procedural solutions, and original equipment manufacturer (OEM). Its endoscopy segment consists of gastroenterology and pulmonology devices which assist in the palliative treatment of expanding esophageal, tracheobronchial and biliary strictures. Its product portfolio of medical devices and accessories used in lead management procedures for patients who need a pacemaker, or an implantable cardioverter-defibrillator lead removed or replaced. Its electrophysiology and cardiac rhythm management portfolio includes steerable and other specialty technologies.
High Growth
The company's revenue has grown steadily over the past 3 years, averaging 17.86% year-on-year.
High Profit Growth
The company's net income leads the industry, with the latest annual income totaling USD 61.52.
Undervalued
The company’s latest PE is 43.78, at a low 3-year percentile range.
Institutional Selling
The latest institutional holdings are 65.62M shares, decreasing 1.15% quarter-over-quarter.
Held by The Vanguard
Star Investor The Vanguard holds 6.82M shares of this stock.
Lower Market Activity
The company has less investor interest, with a 20-day turnover ratio of -0.08.
Merit Medical Systems, Inc. is engaged in the development, manufacture, and distribution of proprietary medical devices used in interventional, diagnostic, and therapeutic procedures, particularly in cardiology, radiology, oncology, critical care, and endoscopy. Its segments include cardiovascular and endoscopy. Its cardiovascular segment consists of four product categories: peripheral intervention, cardiac intervention, custom procedural solutions, and original equipment manufacturer (OEM). Its endoscopy segment consists of gastroenterology and pulmonology devices which assist in the palliative treatment of expanding esophageal, tracheobronchial and biliary strictures. Its product portfolio of medical devices and accessories used in lead management procedures for patients who need a pacemaker, or an implantable cardioverter-defibrillator lead removed or replaced. Its electrophysiology and cardiac rhythm management portfolio includes steerable and other specialty technologies.